跳至主要内容
临床试验/NCT03080324
NCT03080324已完成4 期

Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the ER - a Double-blind Randomized Prospective Study

Azienda Sanitaria dell'Alto Adige1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2016年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
108
试验地点
1
主要终点
Pain - Relief

研究概览

简要总结

The purpose of this study is to determine the non-inferiority of the efficacy of sublingual given fentanyl versus endovenous given fentanyl for patients in the emergency departement.

详细描述

Fentanyl endovenous (ev) is an excellent analgesic drug for pain relief in acute traumatic pain. Fentanyl sublingual (Abstral ®) is an excellent analgesic drug in the breakthrough pain relief in oncologic patients.

The immediate (10 minutes) effect and the ease of administration of sublingual fentanyl could be a possibility for a fast pain relief in remote areas such as mountain rescue missions.

Patients will be recruited according to a randomized list to fentanyl ev or fentanyl sublingual versus placebo oral or placebo ev.

Safety issues like control of vital signs will be warranted

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Trauma on the limbs with a pain score of 4 or more
  • ASA I - II

排除标准

  • children < 18 years
  • cognitive impairment: brain injury, intoxication, analgesia
  • weight under 50 kg and more then 100 kg
  • other injuries like chest trauma with respiratory insufficiency, suspect liver or spleen injury, amputation;
  • chronic analgesic use or misuse
  • fear of needles
  • pregnancy
  • speech difficulties

研究组 & 干预措施

Fentanyl sublingual + Placebo ev

Experimental

Fentanyl 100 µg sublingual in acute sever pain + NaCl 0,9% endovenous to mimic fentanyl ev

干预措施: Placebo ev (Drug)

Fentanyl sublingual + Placebo ev

Experimental

Fentanyl 100 µg sublingual in acute sever pain + NaCl 0,9% endovenous to mimic fentanyl ev

干预措施: Fentanyl sublingual (Drug)

Fentanyl ev + Placebo sublingual

Active Comparator

Fentanyl ev in acute sever pain + Sugar pill manufactured to mimic fentanyl sublingual

干预措施: Fentanyl ev (Drug)

Fentanyl ev + Placebo sublingual

Active Comparator

Fentanyl ev in acute sever pain + Sugar pill manufactured to mimic fentanyl sublingual

干预措施: Placebo sublingual (Drug)

结局指标

主要结局

Pain - Relief

时间窗: 1 hour

Pain - Relief of 2 points on a 11 items pain scale (0 = non pain; 10 = unbearable pain)

次要结局

  • SpO2 (%)(1 hour)
  • Practicability / handling of the two dosage forms of fentanyl in emergencies(1 hour)
  • Patient comfort(1 hour)
  • Adverse drug effects(1 hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elisabeth Gruber

MD

Azienda Sanitaria dell'Alto Adige

研究点 (1)

Loading locations...

相似试验